PJ Kim | Vice President, Business Development
ApiJect

PJ Kim’s 20+ years in regulated pharmaceuticals, healthcare, and clinical trials includes responsibilities in quality, sales, program management, key account management, and corporate strategy. At ApiJect, Mr. Kim is responsible for developing strategic plans for new and existing key accounts in drug delivery design, development, and manufacturing utilizing ApiJect’s technology.
 
Previously, Mr. Kim served as an Executive Director in Syngene International’s NA CDMO business, Served as Head of Commercial and Corporate Development at Pharmaceutical International Inc, and has held various leadership business development roles at Johnson Matthey and Advanced Bioscience Laboratories. As Head of Quality and Regulatory at Cleveland Clinic’s Taussig Cancer Institute, he managed a regulatory and quality team to support NCI regulated IND studies. Mr. Kim earned his MBA from Baldwin-Wallace College and a Bachelor’s in Biology with a Chemistry minor from Case Western Reserve.